Literature DB >> 6849143

Nigral transplants reinnervating the dopamine-depleted neostriatum can sustain intracranial self-stimulation.

P J Fray, S B Dunnett, S D Iversen, A Björklund, U Stenevi.   

Abstract

Transplants of embryonic substantia nigra reinnervated the striatum and were able to sustain intracranial self-stimulation in rats with brain lesions induced by 6-hydroxydopamine. Dopaminergic drugs and alterations in current intensity produced typical changes in response rates. Animals with electrodes implanted into cortical grafts or into the denervated striatum failed to exhibit self-stimulation. These findings suggest that transplanted dopamine neurons convey specific, temporally organized information axonally to the striatum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849143     DOI: 10.1126/science.6849143

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

Review 1.  Transplantation of embryonic dopamine neurons: what we know from rats.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

Review 2.  Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model.

Authors:  J Wickens
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 3.  Behavioural consequences of neural transplantation.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

4.  Immunocytochemical study of PC12 cells grafted to the brain of immature rats.

Authors:  C B Jaeger
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

5.  Intracranial cerebellar grafts: intermediate filament immunohistochemistry and electrophysiology.

Authors:  H Björklund; P Bickford; D Dahl; B Hoffer; L Olson
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

6.  Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol.

Authors:  E L Gardner; W Paredes; D Smith; A Donner; C Milling; D Cohen; D Morrison
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.